RPG Life Sciences Share Price

₹ 2,601.00

+₹71.40 (2.82%)
1D
Last updated 04 Nov, 2026, 15:29 IST
NSE: RPGLIFE
|
Pharmaceuticals

RPG Life Sciences Share Price Today

As of 5 Nov 2026, RPG Life Sciences share price is ₹2,601.00. The stock opened at ₹2,542.00, compared to its previous close of ₹2,529.60. During today's trading session, RPG Life Sciences share price moved in the range of ₹2,522.50 to ₹2,609.00, with an average price of ₹2,565.75 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,733.00 and a high of ₹3,127.80. On the performance front, RPG Life Sciences share price has increased by 7.51% over the last six months and is up 5.52% on a year-on-year basis.

Share price over the last 1 day rose from 2522.50 to 2601.00, ranging between 2522.50 and 2609.00.
₹2,522.50
2.82% up today
₹2,609.00
1D LOW
1D HIGH

RPG Life Sciences Stock Insights

Latest Earning
Op Profit TrendDown by 10.14% QoQ
Latest Earning
Net Profit TrendDown by 7.72% QoQ
Latest Earning
Revenue TrendUp by 8.03% QoQ
Stock Performance
OutperformingBeat Nifty by 10.87 % in last 6 month
Shareholding Pattern
DIIDII increased stake by 14.51%
Shareholding Pattern
FIIFII decreased stake by 8.24%
RPG Life Sciences stock performance
Open₹2,542.00
High₹2,609.00
Low₹2,522.50
Prev. close₹2,529.60
RPG Life Sciences trading activity
Volume9,095
Average traded price₹2,588.29
Last traded time03:29:52 04 Nov
Last traded quantity1
Circuit
L
H
₹2,023.70
₹3,035.50
52-week
L
H
₹1,733.00
₹3,127.80
Mkt Cap Cr
4,194.79
P/E
37.85
P/B
6.1
ROA
9.93%
ROE
15.89%
ROCE
20.87%
Quick Ratio
2.71
EV/EBITDA
23.71

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
RPG LifeScience. has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
RPG LifeScience. appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
RPG LifeScience. earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,25,150.1638.74.769.61%13.79%18.65%2.3122.17
Divis Laboratories2,64,141.2491.0315.8914.6%15.32%19.56%3.559.98
Torrent Pharmaceuticals1,76,300.5084.09.64.7%11.42%11.37%0.7533.48
Laurus Labs1,25,352.4494.0820.6811.58%22.11%20.91%0.6853.48
Zydus Lifesciences1,23,685.4926.914.568.57%18.59%17.35%0.9116.36
Dr. Reddy's Laboratories1,14,351.2041.442.954.79%7.21%8.58%1.3518.91
Cipla1,11,647.7239.413.186.6%8.18%10.8%2.521.15
Mankind Pharma1,02,315.4045.25.827.82%12.76%14.68%0.7424.9
Aurobindo Pharma97,756.7126.352.586.34%9.25%11.76%1.1512.4
Lupin91,300.8316.574.114.47%23.76%24.88%1.429.76

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

RPG Life Sciences Company Background

ISIN
INE105J01010
Sector Market Cap
₹ 4,194.79 Cr

RPG Life Sciences Limited is an India-based research-based pharmaceutical company. The Company operates in the domestic and international markets in the formulations, generics, and synthetic active pharmaceutical ingredients (APIs) space. Its business portfolio includes domestic formulations, international formulations, and APIs. Its domestic formulation business manufactures and markets branded finished dosage formulations in India. The domestic formulations business has a presence in nephrology, oncology, rheumatology, cardiology, respiratory, pain management, vitamins & minerals, gastroenterology, and gynecology & pediatrics. The International Formulations business operates in the generics and branded generics space across Canada, Europe, Australia, New Zealand, and South America. Its products include Azoran, Mofetyl, Arpimune ME, Azathioprine, Quinfamide, Nicorandil, Haloperidol, Risperidone, Tolvaptan, Spironolactone, Sertraline, Naprosyn, Teristrong, and others.

RPG Life Sciences Financial Highlights

  • Revenue: RPG Life Sciences reported revenue of ₹733.06 crore in FY26 vs ₹666.11 crore in FY25. It showed an increase of 10.05% on a yearly basis.
  • Operating Profit: RPG Life Sciences reported an operating profit of ₹154.20 crore in FY26 vs ₹232.88 crore in FY25. It showed a decrease of 33.79% on a year-on-year basis.
  • Net Profit: RPG Life Sciences reported a net profit of ₹115.17 crore in FY26 vs ₹183.24 crore in FY25. It showed a decrease of 37.15% on a yearly basis.

RPG Life Sciences Quarterly Result Highlights

  • RPG Life Sciences reported revenue of ₹215.90 crore in Sep 2026, compared with ₹199.85 crore in Jun 2026, representing an increase of 8.03% on a quarter-on-quarter (QoQ) basis.
  • RPG Life Sciences reported an operating profit of ₹37.04 crore in Sep 2026, compared with ₹41.22 crore in Jun 2026, representing a decrease of 10.14% on a quarter-on-quarter (QoQ) basis.
  • RPG Life Sciences reported a profit of ₹28.22 crore in Sep 2026, compared with ₹30.58 crore in Jun 2026, reflecting a decrease of 7.72% on a QoQ basis.
  • The earnings per share (EPS) of RPG Life Sciences stood at ₹69.64 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
72.95%
FII
0.87%
Other DII
9.89%
Retail and other
16.25%
Mutual funds
0.04%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20251.00%
Mar 20260.87%
Jun 20260.95%
Sep 20260.87%

RPG Life Sciences Investment Returns

1 day
+2.72%
1 week
-8.63%
1 month
-11.34%
1 year
+5.52%
3 years
+74.43%
5 years
+267.43%

RPG Life Sciences Share Price History

RPG Life Sciences share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
04 Nov 26
₹2,542.00 / ₹2,601.00
+2.82%
03 Nov 26
₹2,587.70 / ₹2,529.60
-0.78%
02 Nov 26
₹2,562.80 / ₹2,549.50
-1.02%
30 Oct 26
₹2,812.00 / ₹2,575.70
-14.25%
Show more

RPG Life Sciences Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Revenue₹707.52₹653.43
Other Income₹25.58₹12.68
Total Revenue₹733.10₹666.11
Total Expenses₹582.80₹515.83
Profit Before Tax₹154.20₹232.88
Tax₹39.03₹49.64
Profit After Tax₹115.17₹183.24
EPS - Basic₹69.64₹110.80
EPS - Diluted₹69.64₹110.80

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Profit before tax₹154.20₹232.88
Income before WC changes₹136.89₹156.66
Change in Assets-₹76.45-₹24.20
Change in Liabilities₹33.28-₹1.85
Change in WC-₹43.17-₹26.05
Cash flow from Operations₹56.50₹77.86
Cash flow from Investing₹85.84-₹41.80
Cash flow from Financing-₹20.58-₹27.08
Total Cash Flow₹121.76₹8.98
Cash (Start of the year)₹28.70₹19.72
Cash (End of the year)₹150.46₹28.70

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Non-Current Assets₹233.68₹192.56
Current Assets₹559.48₹465.25
Total Assets₹793.16₹657.81
Current Liabilities₹160.57₹119.83
Net Current Asset₹398.91₹345.42
Non-Current Liabilities₹27.24₹7.45
Equity Capital₹605.35₹530.53
Total Equity & Liabilities₹793.16₹657.81

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹707.52₹653.43₹582.05₹512.81
Other Income₹25.54₹12.68₹7.21₹4.80
Total Revenue₹733.06₹666.11₹589.26₹517.61
Total Expenses₹582.76₹515.83₹471.42₹425.93
Profit Before Tax₹154.20₹232.88₹117.84₹91.68
Tax₹39.03₹49.64₹30.18₹24.04
Profit After Tax₹115.17₹183.24₹87.66₹67.64
EPS - Basic₹69.64₹110.80₹53.01₹40.90
EPS - Diluted₹69.64₹110.80₹53.01₹40.90

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹154.20₹232.88₹117.84₹91.68
Income before WC changes₹136.89₹156.66₹130.76₹104.99
Change in Assets-₹76.44-₹24.20-₹25.44-₹12.96
Change in Liabilities₹33.26-₹1.85₹18.35₹24.02
Change in WC-₹43.18-₹26.05-₹7.09₹11.06
Cash flow from Operations₹56.50₹77.86₹94.36₹90.82
Cash flow from Investing₹51.06-₹41.80-₹79.15-₹105.81
Cash flow from Financing-₹20.58-₹27.08-₹20.31-₹17.12
Total Cash Flow₹86.98₹8.98-₹5.10-₹32.11
Cash (Start of the year)₹28.70₹19.72₹24.82₹56.94
Cash (End of the year)₹115.68₹28.70₹19.72₹24.83

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹268.45₹192.56₹214.78₹155.30
Current Assets₹524.69₹465.25₹298.09₹264.05
Total Assets₹793.14₹657.81₹512.87₹419.35
Current Liabilities₹160.53₹119.83₹130.96₹102.78
Net Current Asset₹364.16₹345.42₹167.13₹161.27
Non-Current Liabilities₹27.24₹7.45₹7.06₹8.97
Equity Capital₹605.37₹530.53₹374.85₹307.60
Total Equity & Liabilities₹793.14₹657.81₹512.87₹419.35
* All values are in INR Crore
RPG Life Sciences market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
RPG Life Sciences technical summary
Bearish indicators2
Neutral indicators3
Bullish indicators3
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
40.15
Neutral
ATR (14)
164.14
Neutral
STOCH(9,6)
8.7
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
23.11
Bearish
UO(9)
50.37
Neutral
ROC(12)
-8.96
Bearish
WillR(14)
-91.3
Bullish
Period
Simple value
Exponential vaue
5D
2700.52
2641.53
10D
2729.75
2708.82
20D
2785.25
2761.19
50D
2773.03
2762.95
100D
2694.94
2657.23
Volume trend — traded volume by day
4 Nov0L
3 Nov0L
2 Nov0L
30 Oct1L
29 Oct1L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

RPG Life Sciences
Pharmaceuticals
Add Stock
Add Another

RPG Life Sciences Returns Calculator

Ex-date: 09 Jul 2026

Top Gainers

SAREGAMA Share Price
₹636.80
+74.6 (+13.27%)
APLLTD Share Price
₹906.70
+103.9 (+12.94%)
GMDCLTD Share Price
₹469.20
+43.6 (+10.24%)
ZEEL Share Price
₹67.87
+6.2 (+10.05%)
REDINGTON Share Price
₹366.75
+31.5 (+9.4%)
See more

Top Losers

SKFINDIA Share Price
₹1395.30
-76.6 (-5.2%)
AIAENG Share Price
₹3219.80
-169.9 (-5.01%)
MTARTECH Share Price
₹6036.50
-276 (-4.37%)
ZYDUSLIFE Share Price
₹1188.10
-52.5 (-4.23%)
ALKYLAMINE Share Price
₹1589.50
-69.3 (-4.18%)
See more

RPG Life Sciences Share Price FAQs

Please be aware that RPG Life Sciences stock prices are subject to continuous fluctuations due to various factors.